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Primary cardiac sarcomas are rare malignant tumors of the heart. Clinical features depend on the site of
tumor and vary from symptoms of congestive heart failure to thromboembolism and arrhythmias.
Echocardiography is helpful but definitive diagnosis is established by histopathology. Surgical resection is
the mainstay of treatment, and the role of chemotherapy and radiotherapy is unclear. We report a case of
primary cardiac sarcoma which presented with signs and symptoms of acute left-sided heart failure.
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P
rimary tumors of the heart are rare entities. Based
on the data of 22 large autopsy series, frequency
is estimated to be approximately 0.02% (1). The
majority of these tumors are benign and are predomi-
nantly myxomas. Primary cardiac sarcomas (PCSs) are
rare malignant primary tumors of the heart, accounting
for almost 20% of all primary cardiac tumors (2). Little is
known about these tumors as studies available on this
matter are mostly confined to case reports and single
institutional case series. Clinical presentation depends
on the site of the tumor and varies from symptoms of
congestive heart failure to thromboembolism and arrhyth-
mias (3). In this report, we present a 35-year-old man
who initially presented with signs and symptoms of
left-sided heart failure caused by a PCS in the left atrium.
Case presentation
A 35-year-old Native American without significant med-
ical history was transferred from another facility for the
evaluation of worsening shortness of breath, cough, and
hemoptysis of over 2 months. He also had a history of
on and off fever, and weight loss of about 20 pounds.
He was a known smoker with a history of occasional
alcohol intake. Family history was unremarkable. There
was no history of recent travel or contact with tuberculo-
sis patients. On examination, vital signs were normal.
Mild pallor was noticed with trace pedal edema. A few
crepitations at the right lung base were noted. Cardiac
examination was unremarkable.
Laboratory examination revealed hemoglobin of
7.5 g/dL and white blood cell count of 7,900/mm
3
(neutrophils 93%). Antinuclear cytoplasmic antibody
(ANCA) panel and antinuclear antibody (ANA) were
negative. A computerized tomography (CT) of the chest
showed right-sided pleural effusion with mediastinal
lymphadenopathy measuring 3.22.2 cm, and a ground
glass density with coarsening of interstitial markings in
bilateral lower lobes (Fig. 1). Pleurocentesis revealed
pinkish fluid with 1,2750/mm
3 red blood cells, 400/mm
3
white blood cells (neutrophils 17%, monocytes 31%,
and lymphocytes 45%), 1.3 g/dL protein, 80 IU/L lactate
dehydrogenase, 115 mg/dL glucose, and pH of 7.49 with-
out any malignant cells. Serum protein and glucose
were 6.6 g/dL and 180 g/dL, respectively. Bronchoscopic
evaluation was also done which was unremarkable.
Transthoracic echocardiogram (TTE) was done which
revealed a large left atrial mass measuring 8.152.2 cm
attached to interatrial septum on the left, causing pul-
monary venous hypertension with an elevated right
ventricular systolic pressure (RVSP). This was followed
by atransesophageal echocardiogram (TEE) that revealed
a mass completely occupying the left atrium and protrud-
ing across the mitral valve into the left ventricle with a
mild mitral regurgitation. There was also invasion of the
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with a severe tricuspid regurgitation (Fig. 2).
At the time of initial presentation with shortness of
breath and hemoptysis, our differential diagnosis was
broad and included connective tissue diseases, tuberculo-
sis, lung malignancy, Wegener’s granulomatosis, and heart
failure. Bronchoscopy and CTof the chest ruled out lung
malignancy. ANA, ANCA, and quantiferon tests were
negative, ruling out SLE, Wegener’s granulomatosis, and
tuberculosis, respectively.
Cardiothoracic surgery was consulted for surgical
excision of the mass, and the patient underwent a limited
excision of the mass along with mitral valve repair.
A post procedure TEE showed an improvement in the
RVSP of 47 mmHg. Biopsy of the mass revealed high
grade undifferentiated pleomorphic neoplasm composed
of atypical cells with hyperchromatic nuclei and scattered
atypical mitotic figures (Fig. 3). An immunochemical
stain was positive for smooth muscle actin and desmin.
Stain was negative for S-100, cytokeratin AE1/AE3,
myogenin, and Myo D1.
A follow-up positron emission tomography (PET) scan
showed residual disease activity in the pulmonary veins.
Patient was started on chemotherapywith ifosfamide
and doxorubicin and was referred to a higher center for
additionalmanagement.Patienthasreceivedfourcyclesof
chemotherapy so far and one dose of radiation treatment.
At 9-month follow up, the patient is doing well without
any complications.
Discussion
Primary cardiac tumors are known to be extremely rare
(4). The majority of these tumors are benign, with the
malignant tumors accounting for only about 25% of
primary cardiac tumors (1). Cardiac sarcomas have been
classified into angiosarcoma, fibrosarcoma, rhabdo-
myosarcoma, leiomyosarcoma, liposarcoma, pleomorphic
malignant fibrious histiocytoma/pleomorphic undifferen-
tiated sarcoma, and synovial sarcoma based on the clas-
sification proposed by WHO in 2004 (2). Among these
subtypes, angiosarcomas and pleomorphic undifferentiated
sarcomas are the most common ones (5).
PCS may arise at any age, with a reported mean age of
41 years (6). There is no specific sex predilection (2). Left
atrium is the most common site of the tumor (2).
Although, clinical presentation varies with the site of
involvement, symptoms of congestive heart failure are the
most common manifestation (4). About a third of these
tumors have evidence of systemic metastasis at diagnosis
(7). PCS located in the left atrium can cause obstruction
of the mitral valve and can present with symptoms of
mitral stenosis including dyspnea, cough, hemoptysis,
and fatigue on exertion (8). Our patient presented with
symptoms suggestive of mitral stenosis and constitu-
tional symptoms of fever, weight loss, and fatigue, which
have been reported previously, particularly with atrial
myxomas (9).
Undifferentiatedpleomorphicsarcoma,asinourcase,is
a high grade malignant tumor characterized histologically
Fig. 1. CTscan without contrast showing right pleural effusion and right hilar adenopathy with suggestion of node or mass with
size of 3.22.2 cm.
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high mitotic activity, and areas of necrosis. In some
cases, such tumors comprise of small embryonal looking
cells with no further recognizable differentiation (10).
Immunohistochemical staining is crucial in these cases
with sarcomas being negative markers for epithelial,
neural, or endothelial elements (2). In our case, immuno-
histochemicalstainingwaspositivefordesminandsmooth
muscle actin suggesting a myogenic origin. However,
absence of staining for S100, cytokeratin, myogenic, and
myoD1 made neural, lipomatous, epithelial tumor or
rhabdomyosarcoma unlikely.
Fig. 2. (a and b) 2-D Echo showing atrial mass originating from left side of the interatrial septum extending beyond mitral valve
to left ventricle (measuring 8.152.24 cm).
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has been reported to be about 5 months (3). The electro-
cardiogram findings are non-specific and include conduc-
tion deficits, low voltage, T-wave changes, and rhythm
abnormalities. A chest X-ray may be normal or show
cardiomegaly (3). Echocardiography is the mainstay of
diagnosis. TEE has been shown to be superior to a TTE in
identifying the presence and site of origin of primary
cardiac tumors (11). Although it might be difficult to
differentiate benign cardiac tumors from malignant ones
based on the echocardiographic findings alone, it has been
suggested that the presence of non-septal origin, broad
attachment on the wall, extension into pulmonary vein,
semisolid consistency, and multiple masses can predict
the likelihood of a left atrial mass being a malignant (12).
A chest CT and MRI can be helpful in the better
delineation of anatomy for surgical planning as well as
for evaluation of tumor extension (3, 13).
Prognosis of PCS remains poor with a reported median
survivalof511months(3,14).Themostimportantfactor
dictating prognosis is the ability to achieve a complete
surgical resection of the tumor. It has been observed that
the median survival increases to 1227 months with
complete resection compared to 410 months where
complete resection is not possible 1521. Hence, resection
of tumor is indicated in all caseswherepossible and has an
added benefit of effective palliation of symptoms (22).
Howeverbecauseofcloseproximitytovitalstructures,itis
not always possible to achieve a complete surgical resec-
tion. The role of neoadjuvant chemotherapy in these cases
remains unclear. Collins et al. reported a 97% reduction
in the tumor size after starting oral etoposide in an
undifferentiated PCS in a 9-year-old girl. The tumor was
subsequently amenable to surgical resection (23). Che-
motherapy has been tried, most commonly with doxor-
ubicin and/or ifosfamide containing regimens, with
unclear survival benefit. However these studies have
been limited by small sample size (12, 15, 19, 20). Hence,
additional studies are warranted to identify the role
of chemotherapy in these patients. Orthotropic cardiac
transplantation has been tried but the experience is
limited (24).
In conclusion, PCS are rare malignant tumors of the
heart with poor prognosis. Clinical features depend on
the site of tumor. In cases of left atrial tumors, patients
present with signs and symptoms of left-sided heart
failure. Echocardiography is helpful but definitive diag-
nosis requires histologic sampling. Surgical resection is
the mainstay of treatment, and the role of chemotherapy
and radiotherapy remains unclear.
Fig. 3. Slide showing pleomorphic neoplasm with atypical cells with hyperchromatic nuclei scattered atypical mitotic ﬁgures.
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